NovoRapid (insulin aspart), a new rapid-acting insulin analog

February 2002

Novo Nordisk is now marketing NovoRapid (insulin aspart), a new rapid-acting insulin analog.

It's available in the U.S. under the brand name Novolog.

NovoRapid is similar to Humalog (insulin lispro).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

ibuprofen might reduce the benefit of taking low-dose ASA
Diabetes NovoRapid (insulin aspart), a new rapid-acting insulin analog
Infectious Diseases single-dose or three-day regimens of Zithromax (azithromycin) for acute otitis media in children
Infectious Diseases HIV patients taking the new Videx EC capsules
Hematology & Oncology Arimidex (anastrozole) is more effective than tamoxifen for EARLY breast cancer
Cardiology Tracleer (bosentan), the first ORAL drug approved for pulmonary arterial hypertension
Cardiology whether to treat patients with "white-coat hypertension
Cardiology iron supplements can suppress the cough caused by ACE inhibitors
frequent use of triptans (Imitrex, etc) can actually EXACERBATE migraines
Some products containing ephedra or ephedrine are now being voluntarily recalled
ginkgo can cause seizures
whether vitamin A causes hip fractures
Women's Health women ask if they can insert their birth control pill VAGINALLY
Women's Health whether antibiotics reduce the efficacy of oral contraceptives
Aerius, the new OTC non-sedating antihistamine
Alzheimer's Disease NSAIDs reduce the risk of Alzheimer's
Practice chart of new drugs approved by the FDA in 2001